Skip to content

Clinical trials

Completed Lymphoma, B-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Completed Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20102
20112
20132
20161
20171
20183
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Amgen1
AstraZeneca1
Biogen1
Epizyme, Inc.1
Gustave Roussy, Cancer Campus, Grand Paris1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Juno Therapeutics, a Subsidiary of Celgene1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell18
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Non-Hodgkin8
Lymphoma6
Lymphoma, Follicular4
Recurrence4
Burkitt Lymphoma2
Dendritic Cell Sarcoma, Interdigitating2
Lymphoma, Mantle-Cell2
Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.